title: [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
abstract: Dysplasia is the only marker for malignant potential in Barrett's esophagus. The histologic interpretation of dysplasia is sometimes difficult, particularly when attempting to distinguish dysplastic changes from those of a regenerating and inflammatory mucosa. In order to find an objective marker to identify patients with high risk of malignant transformation, the authors evaluated 497 biopsies from 66 patients with Barrett's esophagus with flow cytometry. The aim of the study was to correlate DNA content and proliferative abnormalities with histology. All biopsies classified histologically as negative for dysplasia had a diploid DNA content. The percentage of biopsies with an aneuploid DNA content increased with the histologic grade of dysplasia: 2 percent of indefinite dysplasia, 11 percent of low grade dysplasia, 44 percent of high grade dysplasia and 78 percent of biopsy specimens with cancer biopsies were aneuploid. Mean S and G2M fractions of diploid biopsy specimens increased with the severity of histologic changes. The S and G2M fraction threshold values that could differentiate patients that were negative for dysplasia from those with high grade dysplasia or cancer were 9 percent and 6 percent, respectively. Aneuploidy or G2M fraction greater than 6 percent was the best discriminating criteria between those two distinct groups of patients. All 6 patients with high grade dysplasia or cancer had aneuploid cell populations or increased G2M fraction, whereas none of the 35 patients whose biopsies were histologically negative for dysplasia had evidence of genomic instability or increased G2M fraction. Flow cytometric abnormalities were found in 10 out of 25 patients whose biopsies were classified as indefinite for dysplasia or low grade dysplasia.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service d'Hépato-Gastroentérologie, Centre Hospitalier Universitaire Morvan, Brest.
authors.forename: M
authors.initials: M
authors.lastname: Robaszkiewicz
authors.forename: E
authors.initials: E
authors.lastname: Hardy
authors.forename: A
authors.initials: A
authors.lastname: Volant
authors.forename: J B
authors.initials: JB
authors.lastname: Nousbaum
authors.forename: J M
authors.initials: JM
authors.lastname: Cauvin
authors.forename: G
authors.initials: G
authors.lastname: Calament
authors.forename: F X
authors.initials: FX
authors.lastname: Robert
authors.forename: J P
authors.initials: JP
authors.lastname: Saleun
authors.forename: H
authors.initials: H
authors.lastname: Gouerou
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001471:Barrett Esophagus / Q000150:complications / Q000235:genetics* / Q000473:pathology; D001706:Biopsy; D004247:DNA / Q000032:analysis*; D004938:Esophageal Neoplasms / Q000209:etiology* / Q000473:pathology; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D016195:G2 Phase; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D016196:S Phase
chemical_list: D004247:DNA
vernacular_title: Analyse du contenu cellulaire en ADN par cytométrie en flux dans les endobrachyoesophages. Etude de 66 cas.